Which Health Systems Have Venture Funds?

A hospital venture fund is not the same thing as an innovation center. In the first ten directory prototypes, several health systems publish a dedicated investment function. The mandates differ, and each is one possible part of a broader hospital innovation program.

This article reports only what those systems have said about their own funds. It is not a league table and it does not infer returns.

Funds that primarily invest in external companies

Kaiser Permanente Ventures describes itself as a corporate venture capital arm founded in 1998. Official materials say the firm has invested in and supported more than 67 companies and that it targets health information technology, digital health, healthcare services, medical devices, and diagnostics and precision medicine.

Intermountain Ventures describes itself as the venture capital and innovation arm of Intermountain Health. The official page lists six investment areas and publishes named portfolio companies. It also states that portfolio companies can use Intermountain's system for proofs of concept, trials, and pilots.

Those two records are useful because they make the investment thesis visible. They do not, by themselves, tell an executive whether the fund is the system's only innovation function.

Funds connected to academic commercialization offices

Mass General Brigham Ventures is described on the official Innovation site as an early-stage venture firm founded in 2008 to advance life science technologies emerging from the system. A separate Artificial Intelligence and Digital Innovation Fund, founded in 2020 with a $30 million commitment, is also named on that page. The official Chief Innovation Officer biography states that the venture investment arm has nearly $500 million under management.

Mayo Clinic publishes venture investing as one function inside the Department of Business Development, alongside licensing, startup formation, and strategic collaborations. Official pages state that more than $400 million in investment capital has been deployed for strategic collaborations and equity investments from inception through 2025.

Cedars-Sinai identifies Cedars-Sinai Health Ventures in official Accelerator leadership biographies and describes Technology Ventures as the home for intellectual property and venture investment.

Investment arms that also form companies

UPMC Enterprises describes itself as the innovation, commercialization, and venture capital arm of UPMC. Official pages say the team invests in and forms companies in translational sciences and digital solutions. The 2025 annual report names nine companies that joined the portfolio that year.

Northwell Holdings describes a for-profit arm that invests in external companies and commercializes internal innovations. Official copy states that Holdings seeks companies that can diversify revenue streams for the health system.

What this pattern means for hospital executives

The presence of a fund is evidence of allocated capital and a chosen commercial route. It is not evidence that the rest of the innovation portfolio is being commercialized, or that it is not.

A useful private question is not "Do we have a fund?" It is "Which assets in our portfolio are best served by investment, license, spinout, partnership, or direct sale, and who owns that decision?"

Explore the venture fund and investment pages for the current sourced set.

How does your innovation program compare? Request a confidential conversation about the commercial opportunities, market pathways, and capabilities within your hospital's innovation portfolio.